Dev48
Language
  • About
  • Services
  • Industries
  • Technologies
  • Articles
  • Contacts
Book a call
    Home/Articles/Bd named to us news and world report inaugural list of best employers
Dev48
info@dev48.org+375 29 320-40-96WhatsApp@isky_by

© 2026 · All rights reserved.

BD Named to U.S. News and World Report Inaugural List of Best Employers

Source: Becton Dickinson•September 29, 2026 at 10:36 AM

BD Named to U.S. News and World Report Inaugural List of Best Employers

FRANKLIN LAKES, N.J. (July 13, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it is one of 200 companies named to U.S. News & World Report’s 2023-2024 “Best Companies to Work For” list.

FRANKLIN LAKES, N.J. (July 13, 2023) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it is one of 200 companies named to U.S. News & World Report’s 2023-2024 “Best Companies to Work For” list.

The inaugural ranking evaluated companies based on how well they meet employees’ expectations, with measures including quality of pay and benefits, work-life balance and flexibility, job and company stability, physical and psychological comfort, belongingness and esteem, and career opportunities and professional development.

“This recognition is a testament to the emphasis we place on empowering our teams through a focus on developing servant leaders, supporting employee well-being, and advancing our inclusion, diversity and equity strategy,” said Shana Neal, executive vice president and chief people officer for BD. “These efforts that enable BD employees to excel in their careers and advance our culture are priorities that help us continue to accelerate progress against our BD 2025 strategy.”

To calculate the list, U.S. News & World Report only considered companies that were a part of the Russell 1000 index as of June 2022 and had more than 75 Glassdoor reviews written in 2022. The methodology, developed with the support of a panel of six experts, also factors in data, including employee sentiment, gathered from U.S. News & World Report partners Revelio Labs and ESG Book.

This year BD was also included in the 2023 Bloomberg Gender-Equality Index, named a "Noteworthy Company" in DiversityInc's annual ranking of the top U.S. companies for diversity, and earned a perfect score as a best place to work for disability inclusion.

These recognitions reflect the company's efforts in advancing its environmental, social, and governance (ESG) strategy to achieve its 2030+ goals for promoting a healthy workforce and communities. These goals encompass maintaining a healthy and thriving workforce that cultivates the company's culture of inclusion, safety, well-being, and also contributes to community and company health.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 77,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:

Media:

Troy Kirkpatrick VP, Public Relations 858.617.2361 troy.kirkpatrick@bd.com

Investors:

Francesca DeMartino SVP, Head of Investor Relations 201.847.5743 francesca.demartino@bd.com

← All articles

What this article says

More in HealthTech & MedTech

All →
Building the Foundation for Agentic Safety | Veeva
Veeva Systems

Building the Foundation for Agentic Safety | Veeva

How athenaOne® unifies AI across the clinical workflow
Athenahealth

How athenaOne® unifies AI across the clinical workflow

From months to days: how nanopore sequencing is transforming genomic investigations at VCGS
Oxford Nanopore

From months to days: how nanopore sequencing is transforming genomic investigations at VCGS

Oxford Nanopore marks a decade of sequencing in space
Oxford Nanopore

Oxford Nanopore marks a decade of sequencing in space

Inovalon To Acquire Intelligent Medication Management Company DrFirst
Inovalon

Inovalon To Acquire Intelligent Medication Management Company DrFirst

Sonova HY 2026/27 results: Raising full-year guidance after strong first half
Sonova

Sonova HY 2026/27 results: Raising full-year guidance after strong first half

More from Becton Dickinson

Singapore – BD receives the prestigious National Award (COVID-19)
Becton Dickinson

Singapore – BD receives the prestigious National Award (COVID-19)

BD Issues FY 2022 ESG Report, Highlights Notable Progress in Energy and Waste Reduction, Health Care Access and Diversity
Becton Dickinson

BD Issues FY 2022 ESG Report, Highlights Notable Progress in Energy and Waste Reduction, Health Care Access and Diversity

Vulnerability disclosures help protect patients and build trust
Becton Dickinson

Vulnerability disclosures help protect patients and build trust

BD Inaugurates China First Digitalized Comprehensive Training and Innovation Center
Becton Dickinson

BD Inaugurates China First Digitalized Comprehensive Training and Innovation Center